PSI will leverage technology to gain insights as well as excite and support users across India, Nigeria and Uganda in new ways and drive rapid and sustainable increases in self-injection of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC). By leveraging technology, PSI will connect consumers to the information, services and products they want—when and where they want them—at decreased out-of-pocket costs.
Delivering Innovation in Self-Care (DISC)
- Donor: Children’s Investment Fund Foundation
